We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLY icon
5201
Fastly Inc
FSLY
$3.55B
$558K ﹤0.01%
13,808
-419,756
-97% -$19.4M
TVRD
5202
Tvardi Therapeutics
TVRD
$19.7M
$557K ﹤0.01%
+1,002
New +$503K
MSAC
5203
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$557K ﹤0.01%
57,149
NKTX icon
5204
PUT
Nkarta
NKTX
$150M
$556K ﹤0.01%
+20,000
New +$634K
BSRR icon
5205
Sierra Bancorp
BSRR
$528M
$555K ﹤0.01%
22,877
+10,119
+79% +$246K
MLTX icon
5206
MoonLake Immunotherapeutics
MLTX
$1.57B
$555K ﹤0.01%
55,735
FLUX icon
5207
Flux Power
FLUX
$11.2M
$554K ﹤0.01%
+108,971
New +$921K
VRSN icon
5208
PUT
VeriSign
VRSN
$26.2B
$554K ﹤0.01%
2,700
XERS icon
5209
Xeris Biopharma Holdings
XERS
$1.39B
$554K ﹤0.01%
226,239
-228,298
-50% -$663K
GFF icon
5210
Griffon
GFF
$3.95B
$552K ﹤0.01%
+22,437
New +$535K
DOC
5211
DELISTED
PHYSICIANS REALTY TRUST
DOC
$552K ﹤0.01%
31,326
-369,090
-92% -$6.82M
QNCX icon
5212
CALL
Quince Therapeutics
QNCX
$22.9M
$550K ﹤0.01%
+30
New +$477K
KOR
5213
DELISTED
Corvus Gold Inc. Common Shares
KOR
$548K ﹤0.01%
+171,788
New +$534K
GHG
5214
GreenTree Hospitality
GHG
$117M
$546K ﹤0.01%
66,937
+54,230
+427% +$499K
YI
5215
111 Inc
YI
$33.9M
$546K ﹤0.01%
8,853
+6,521
+280% +$435K
NPK icon
5216
National Presto Industries
NPK
$870M
$544K ﹤0.01%
+6,626
New +$594K
CYTK icon
5217
CALL
Cytokinetics
CYTK
$10.5B
$543K ﹤0.01%
+15,200
New +$447K
RRC icon
5218
CALL
Range Resources
RRC
$9.38B
$543K ﹤0.01%
+24,000
New +$389K
ILLM
5219
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$543K ﹤0.01%
+81,081
New +$664K
WPCB
5220
CALL
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$543K ﹤0.01%
583,508
+260,000
+80% +$2.54M
SCVX.U
5221
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
$543K ﹤0.01%
53,037
EDIT icon
5222
Editas Medicine
EDIT
$396M
$541K ﹤0.01%
+13,174
New +$722K
IGSB icon
5223
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$541K ﹤0.01%
9,893
-53,388
-84% -$2.92M
INSE icon
5224
Inspired Entertainment
INSE
$184M
$541K ﹤0.01%
46,201
+26,880
+139% +$314K
ROOT icon
5225
Root
ROOT
$857M
$541K ﹤0.01%
5,707
+4,446
+353% +$552K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.